4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0001209191-23-056803
Chief Technology Officer acquired 104,516 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tyagarajan Seshu Chief Technology Officer | 2023-11-26 | Grant or award | +104,516 | 191,558 | D |
Loading xslF345X05/doc4.xml…